Sections
Business | Pulse | Labour & Employment | Wills, Trusts & Estates | Family | Criminal | Civil Litigation | Personal Injury | Access to Justice
In-House Counsel | Insurance | Intellectual Property | Immigration | Natural Resources | Real Estate | Tax

Otsuka, Lundbeck agree to settle antipsychotic drug class action for $4.75M

By Karunjit Singh ( August 26, 2025, 11:47 AM EDT) -- Pharmaceutical companies Otsuka Canada and Lundbeck Canada have agreed to a proposed $4.75-million settlement in a class action alleging that their antipsychotic drug Rexulti may cause compulsive behaviours, including hypersexuality, compulsive gambling and binge eating....

Related Sections